Why the study?
Does NT-proBNP testing predict mortality and cardiovascular hospitalization in primary care patients with suspected heart failure?
Does NT-proBNP testing predict mortality and cardiovascular hospitalization in primary care patients with suspected heart failure?
Specific NT-proBNP threshold levels can effectively risk-stratify primary care patients with suspected heart failure for mortality and cardiovascular hospitalization, potentially optimizing triage for echocardiography.
Answers are grounded in this paper and cite their sources.
May support NT-proBNP thresholds for risk stratification in suspected HF; hypothesis-generating and requires prospective validation before guiding triage.
AIMS: Chronic heart failure (HF) is a common condition with a poor prognosis. As delayed diagnosis and treatment of HF patients in primary care can be detrimental, risk-stratified waiting lists for echocardiography might optimize resource utilization. We investigated whether a prognostic threshold level of the cardiac peptide, NT-proBNP, could be identified. METHODS AND RESULTS: From 2003-2005, 5875 primary care patients with suspected HF (median age 73 years) had NT-proBNP analysed in the Copenhagen area. Eighteen percent died and 20% had a cardiovascular (CV) hospitalization (median follow-up time: 1127 and 1038 days, respectively). In Cox proportional hazards regression models regarding NT-proBNP levels, the fourth decile (range: 83-118 pg/mL) was associated with a 90% (95% CI: 30-190, P < 0.01) increased risk for CV hospitalization and the seventh decile (range: 229-363 pg/mL) was associated with an 80% (95% CI: 20-190, P = 0.01) increased mortality risk after adjustment for age, sex, previous hospitalization, CV diseases, and chronic diseases. CONCLUSION: We identified prognostic threshold levels for mortality and CV hospitalization for NT-proBNP in primary care patients suspected of HF. Our results have the potential to be used to risk-stratify waiting lists for echocardiography.
No takes yet. Share an insight, caveat, or question.
Rosenberg et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: